Babichev, Y., Kabaroff, L., Datti, A., Uehling, D., Isaac, M., Al-awar, R., . . . Gladdy, R. A. (2016). PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma. J Transl Med.
Styl cytowania ChicagoBabichev, Yael, et al. "PI3K/AKT/mTOR Inhibition in Combination With Doxorubicin Is an Effective Therapy for Leiomyosarcoma." J Transl Med 2016.
Styl cytowania MLABabichev, Yael, et al. "PI3K/AKT/mTOR Inhibition in Combination With Doxorubicin Is an Effective Therapy for Leiomyosarcoma." J Transl Med 2016.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..